This finding was also assessed by Charity [17] in a retrospective study on resected stage IIB osteosarcomas around the knee: VEGF expression in more than 25% of tumor cells after neoadjuvant chemotherapy correlated with shorter overall and disease-free survival. This evidence concerns the gene VEGFA and osteosarcoma.